Compare ALSN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALSN | BIO |
|---|---|---|
| Founded | 1915 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.7B |
| IPO Year | 2012 | N/A |
| Metric | ALSN | BIO |
|---|---|---|
| Price | $109.89 | $314.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $100.57 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 792.2K | 185.7K |
| Earning Date | 02-10-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.15 | N/A |
| Revenue | ★ $3,069,000,000.00 | $2,557,500,000.00 |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | $0.23 | $2.26 |
| P/E Ratio | $13.52 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $76.01 | $211.43 |
| 52 Week High | $121.81 | $373.69 |
| Indicator | ALSN | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 73.00 | 50.47 |
| Support Level | $99.13 | $316.57 |
| Resistance Level | $112.21 | $328.56 |
| Average True Range (ATR) | 2.54 | 8.58 |
| MACD | 0.65 | 0.74 |
| Stochastic Oscillator | 84.90 | 52.38 |
Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.